zelicapavir (therapeutic dose)
EDP 938-008
Phase 1 small_molecule completed
Quick answer
zelicapavir (therapeutic dose) for RSV Infection is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- RSV Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed